证券记录 · 已归档季度
ICLR
ICON Public Limited Company · Healthcare · Medical - Diagnostics & Research
17被追踪持有人
+3Δ持有人
17.03M持有股份
$2.48B报告持仓市值
+3新建仓位
−0清仓
动量输入（同类管理人）：
持有人广度 +21.4% ·
股份流向 +30.0% ·
净新建仓位 +17.6%
· 公式
广泛增持：持股数量上升，持有人数量增加
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 111 | +2 | 54.20M | $9.33B | +10 | −9 |
| Q1 2026 | 112 | -7 | 49.87M | $5.61B | +7 | −15 |
| Q4 2025 | 119 | -2 | 53.17M | $9.70B | +2 | −3 |
| Q3 2025 | 18 | -1 | 14.11M | $2.47B | +2 | −4 |
| Q2 2025 | 17 | +3 | 17.03M | $2.48B | +3 | n/a |
| Q1 2025 | 11 | -1 | 10.01M | $1.75B | +1 | −2 |
| Q4 2024 | 12 | -1 | 9.48M | $1.99B | +2 | −3 |
| Q3 2024 | 12 | -1 | 9.43M | $2.71B | +1 | −2 |
| Q2 2024 | 13 | n/a | 9.47M | $2.97B | n/a | n/a |
持有人 · Q2 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 3.66M | -0.8% | $532.62M | 0.1% | ▼ Trim | 5 | SEC ↗ ×9 |
| 2 | D. E. Shaw & Co. ✦ | 2.43M | +46.5% | $354.03M | 0.4% | ▲ Add | 5 | SEC ↗ ×2 |
| 3 | Fidelity (FMR) ✦ | 1.96M | n/a | $285.73M | 0.0% | n/c | 1 | SEC ↗ ×6 |
| 4 | Citadel Advisors ✦ | 1.95M | +175.9% | $283.07M | 0.2% | ▲ Add | 5 | SEC ↗ ×2 |
| 5 | Harris Associates (Oakmark) ✦ | 1.64M | 新增 | $238.26M | 0.4% | New | 1 | SEC ↗ |
| 6 | T. Rowe Price ✦ | 1.19M | -30.6% | $172.74M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 7 | Norges Bank ✦ (被动) | 1.09M | +4.6% | $158.64M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 8 | Millennium Management ✦ | 617.90K | +435.3% | $89.87M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 9 | Point72 Asset Management ✦ | 535.79K | +840.9% | $77.93M | 0.2% | ▲ Add | 5 | SEC ↗ |
| 10 | State Street Global Advisors ✦ (被动) | 417.59K | +17.4% | $60.74M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 11 | Baupost Group ✦ | 405.00K | 0.0% | $58.91M | 1.4% | Held | 2 | SEC ↗ |
| 12 | BlackRock ✦ (被动) | 326.55K | n/a | $47.50M | 0.0% | n/c | 1 | SEC ↗ ×16 |
| 13 | Renaissance Technologies ✦ | 324.82K | +81.5% | $47.25M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 14 | The Vanguard Group ✦ (被动) | 225.02K | n/a | $32.73M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 15 | Two Sigma Investments ✦ | 132.62K | 新增 | $19.29M | 0.0% | New | 1 | SEC ↗ |
| 16 | Geode Capital Management ✦ (被动) | 84.37K | +2.6% | $12.27M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 17 | Adage Capital Partners ✦ | 36.23K | 新增 | $5.27M | 0.0% | New | 1 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| Harris Associates (Oakmark) | $238.26M | 0.4% |
| Two Sigma Investments | $19.29M | 0.0% |
| Adage Capital Partners | $5.27M | 0.0% |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 414 持有人, 78.10M 股份, $8.66B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Sep 17
McCague Eugene Pacelli
Director · 3.25K 股 · $569,625
Sep 17
Murphy Ronan Martin
Director · 5.00K 股 · $875,875
Sep 16
CLIMAX JOHN DR
Director · 5.00K 股 · $875,875
Aug 11
Clerkin Nigel Bernard John
Officer · 259 股 · $42,416
Aug 11
Clerkin Nigel Bernard John
Officer · 1.59K 股 · $261,672
Aug 11
Clerkin Nigel Bernard John
Officer · 180 股 · $29,792
Aug 11
Grais Linda
Director · 87 股 · $14,157
Aug 11
Grais Linda
Director · 97 股 · $15,886
Aug 11
Grais Linda
Director · 590 股 · $97,037
Aug 11
Grais Linda
Director · 67 股 · $11,089
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Aug 13
SC 13G/A: Invesco Ltd.
Aug 06
SC 13G/A: FMR LLC
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2025 ·
方法论 ·
通过API获取此数据